Previous studies indicate downregulation of Bcl-2 in the presence of DATS in human pancreatic (Ma et al. 2014), epithelial ovarian (Wan et al. 2013), leukemia (Choi and Park 2012), lung (Li et al. 2012), breast (Malki et al. 2009), and prostate (Kim et al. 2007) cancer cell lines. Here, BCL2 is linked to leukemia.